iifl-logo

Panacea Biotec Ltd Quarterly Results

538.35
(4.95%)
Apr 24, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Dec-2024Sept-2024Jun-2024Mar-2024Dec-2023

Gross Sales

163.49

147.35

115.72

136.46

150.5

Excise Duty

0

0

0

0

0

Net Sales

163.49

147.35

115.72

136.46

150.5

Other Operating Income

0

0

0

0

0

Other Income

6.39

7.42

6.54

13.55

8.46

Total Income

169.88

154.77

122.26

150.01

158.96

Total Expenditure

155.53

140.35

129.71

142.5

150.65

PBIDT

14.35

14.42

-7.45

7.51

8.31

Interest

0.99

0.98

0.87

0.82

0.85

PBDT

13.36

13.44

-8.32

6.69

7.46

Depreciation

8.98

8.68

8.73

8.81

9.11

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

0.07

0.62

Deferred Tax

-0.06

0.05

-1.17

-0.2

-0.07

Reported Profit After Tax

4.44

4.71

-15.88

-1.99

-2.2

Minority Interest After NP

-0.08

-0.09

0

0

0.08

Net Profit after Minority Interest

4.52

4.8

-15.88

-1.99

-2.28

Extra-ordinary Items

2.77

2.74

2.74

2.67

2.16

Adjusted Profit After Extra-ordinary item

1.75

2.06

-18.62

-4.66

-4.44

EPS (Unit Curr.)

0.74

0.77

-2.59

-0.23

-0.37

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

6.13

6.13

6.13

6.13

6.13

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

8.77

9.78

-6.43

5.5

5.52

PBDTM(%)

8.17

9.12

-7.18

4.9

4.95

PATM(%)

2.71

3.19

-13.72

-1.45

-1.46

Panacea Biotec: Related NEWS

Panacea Biotec Wins ₹127 Crore UNICEF Deal to Supply Polio Vaccines
27 Dec 2024|05:23 PM

Such a contract symbolizes Panacea Biotec's continued commitment toward global health by contributing its share of the fight against polio, a deadly disease prevalent in many pockets of the world.

Read More
Panacea Biotec Shares Gain Amid Karnataka's Dengue Epidemic Declaration
4 Sep 2024|09:31 AM

Panacea Biotec's stock has seen a 37% gain over the past six months. Panacea Biotec's stock has gained a total of 76% in the last one year.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.